Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Cakradonya Dental Journal
Ahmad Syaify
Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Effect uf Injectable Platelet-Rich Fibrin (i-PRF) as Regenerative Periodontal Biomaterials: A Systematic Review Ardian Sari Rakhmawati; Ahmad Syaify; Zurairah Binti Berahim; Kwartarini Murdiastuti
Cakradonya Dental Journal Vol. 18 No. 2 (2026): August
Publisher : FKG Universitas Syiah Kuala

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24815/cdj.v18i2.1707

Abstract

Injectable platelet-rich fibrin (i-PRF) is a liquid autologous platelet concentrate that may enhance periodontal healing and facilitate the delivery of graft particles or locally administered drugs. This systematic review evaluated the clinical and biological effectiveness of i-PRF for periodontal regeneration and compared it with conventional therapy and other regenerative materials. Following PRISMA 2020, Google Scholar, PubMed, and the Cochrane Library were searched for controlled human, in vivo, and in vitro studies published from 2018 to 2025. Fourteen studies met the eligibility criteria: 12 human clinical studies, one animal study, and one in vitro study. Adjunctive i-PRF generally improved probing pocket depth, clinical attachment level, bleeding indices and radiographic defect fill when combined with scaling and root planing, minimally invasive surgery, open-flap debridement or bone grafts. Reported clinical improvements included PPD reductions of approximately 2.80 - 4.20 mm and CAL gains of approximately 2.40 - 3.80 mm. Experimental evidence also supported anti-inflammatory activity, osteogenic responses and favorable cytocompatibility. No major safety concerns were reported. i-PRF is a promising and practical adjunct for periodontal regeneration, but standardized preparation protocols, larger samples, longer follow-up, and direct comparative trials are warranted before universal superiority can be concluded.
Co-Authors Ardian Sari Rakhmawati Kwartarini Murdiastuti Zurairah Binti Berahim